Gemcitabine/VinorelbineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71883-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：190 / 190

相关论文

共 50 条

[31] Gemcitabine/oxaliplatin/pegaspargaseLack of efficacy: case report
Reactions Weekly, 2022, 1937 (1) : 225 - 225
[32] Durvalumab/Gemcitabine/PaclitaxelLack of efficacy: case report
Reactions Weekly, 2025, 2055 (1) : 136 - 136
[33] Gemcitabine/Oxaliplatin/PaclitaxelLack of efficacy: case report
Reactions Weekly, 2024, 2039 (1) : 233 - 233
[34] Carboplatin/gemcitabine/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1920 (1) : 137 - 137
[35] Cisplatin/gemcitabine/nivolumabLack of efficacy: case report
Reactions Weekly, 2023, 1960 (1) : 144 - 144
[36] Cisplatin/gemcitabine/trastuzumabLack of efficacy: case report
Reactions Weekly, 2022, 1919 (1) : 184 - 184
[37] Cisplatin/gemcitabine/tislelizumabLack of efficacy: case report
Reactions Weekly, 2022, 1933 (1) : 151 - 151
[38] Gemcitabine/olaparib/paclitaxelLack of efficacy : case report
Reactions Weekly, 2022, 1887 (1) : 339 - 339
[39] Gemcitabine/paclitaxel/plasmaLack of efficacy: case report
Reactions Weekly, 2023, 1980 (1) : 196 - 196
[40] Carboplatin/gemcitabine/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1928 (1) : 111 - 111

← 1 2 3 4 5 →